Nyenta.com

Menu
  • Home
  • Business
  • Financial
  • Services
  • Entertainment
  • Books
  • Technology
  • Publishing
  • Music
Menu

OBY Introduces a Patented Wearable Connector Designed to Simplify Everyday Access to Essential Devices
Nyenta.com/10351880

Trending...
  • CouponDonation Eliminates Charity Fraud With Store-Verified Voucher Innovation
  • ALight Technology And Services Limited Advances Through Peachscore + Dealum Accelerator and Join LvlUp Labs
  • GeronimoLux Offers Private Chauffeur Service in New York With Live Flight Tracking
Chatgpt Image Jul 15, 2026, 09 17 29 Am
A versatile attachment solution for professionals and consumers alike

CHICAGO - Nyenta -- Axis International proudly presents OBY, a patented wearable connector concept created to improve the way people carry and access everyday accessories while working or on the go.

As wearable technology and communication devices continue to become part of daily life, many professionals struggle with keeping microphones, earbuds, identification badges, and other accessories secure and readily available.

OBY addresses this need by providing a convenient wearable attachment system designed to organize and support essential accessories without interfering with daily movement.

More on Nyenta.com
  • Coming Up on Bloomberg: Kim Natovitz, a Leading Voice in Long-Term Care Planning, Champions Long-Term Care Awareness Month on Moving America Forward
  • Tool Steel Demand Holds Firm as Asia Pulls Ahead, Heading Toward $5.8 Billion by 2032
  • Brian G. Miller Co., LLC Receives Tier 1 Ranking in the 2027 Edition of Best Law Firms®
  • Sliding Patio Door Repair Long Island: WindowFixGuru™ Highlights Repair Services in Jericho
  • Window Frame Repair Long Island: WindowFixGuru™ Highlights Rotten Wood Repair in Roslyn

Potential industries include:
  • Healthcare
  • Emergency services
  • Construction
  • Manufacturing
  • Warehousing
  • Hospitality
  • Education
  • Retail
  • Logistics
  • Consumer lifestyle products

The adaptable design allows manufacturers to explore numerous product applications while meeting the growing demand for convenient wearable organization solutions.

OBY is currently available for licensing through Axis International.

Companies interested in licensing opportunities are encouraged to contact Axis International for additional information.https://123axis.com/in-the-news/

Contact
ANDY BERGER
***@aol.com


Source: Axis International Marketing
Filed Under: Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Nyenta.com
  • "Santa Claus In Concert" Is Coming To The Triad Theater For An Enchanted NYC Christmas
  • ZenaTech (NAS DAQ: ZENA) $1 Million in New Utility Contracts- Potential $2.5 Million Follow-On Opportunity Puts Its Drone Business in the Spotlight!
  • New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
  • Genuine Hospitality, LLC Selected to Operate Holiday Inn Express & Suites Jacksonville – Town Center
  • Mercedes Sánchez to Host Free Fertility Education Seminar in The Bronx on November 13
  • Shiokly Launches Online Marketplace to Help Singapore Home-Based Businesses Sell More, With First Product Listed Free
  • Freight Broker 911 and Milton Collier Introduce "What's The 911?"—A New Podcast Built on Real Talk, Real Freight, and Real Opportunity
  • The Green Room 42 Presents Vickie & Nickie's Holiday Sleigh Ride!
  • PropAccount.com Launches PropWallet, Turning Prop Firm Payouts Into Repeat Sales
  • KOLBUS America, For All Of Your Hycorr Equipment And Service Needs
  • Heritage at Hopewell Announces New 3.875% Year-One Mortgage Rate Buydown Incentive on Quick Delivery Townhomes (7.11% APR)
  • New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
  • Landscapers.city Launches Free Directory of Local Landscapers Across 312 US Cities
  • Advanced Computer Innovations Launches EDGARtag.AI™, an Affordable, Fully Automated Self-Service AI-driven Inline XBRL Tagging Platform for SEC Fil
  • Rent a Truck or Hire Movers? New Data Shows Fuel Now Makes Up to 40% of DIY Moving Costs
  • Buccellati-Attributed Diamond Pendant and 1880 West & Son Ewer Lead SJ Auctioneers' Nov. 22 Sale
  • Club Wyndham Research Identifies the "Holiday Rewind Effect": 93% of Parents Recreate Their Own Childhood Holidays for Their Kids
  • IEI Rugged IP66 Panel PC Brings Real-Time Visibility to Heavy-Duty Mining Fleets
  • Legacy Wise Experiences Adds "Reserve Now, Pay Before You Go" Payment Options at Checkout
  • FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc

Popular on Nyenta

  • Clinical Psychologist Launches The Redesign Institute to Rethink Burnout and Workplace Wellbeing - 277
  • Thunderbird F-16 Arrives 11/11 - 113
  • BREAKING: Teenage Field Guide to Fake Socials. It's all about poop! - 112
  • The Real Measure Of A Story Is What Remains After The Plot Is Forgotten - 111
  • Broken or Foggy Window Glass in Merrick Does Not Always Mean You Need a New Window - 102
  • Window Glass Repair in White Plains Can Be an Alternative to Replacing the Entire Window
  • Lifestyle Prediction Markets Bring Everyday Trends Into the Spotlight as Free-to-Play Platforms Gain Popularity
  • Little Elara By Michael Evans Invites Children to Listen to Their Inner Voice
  • HSS Medical Supply Celebrates One-Year Anniversary of Its Top Performing Sales Team
  • Goosechase Powers NYC's Citywide Scavenger Hunt

Similar on Nyenta

  • New Omega-3 Fish Oil Under NIH Investigation: What Makes It Different From EPA and DHA?
  • OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
  • New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
  • New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
  • FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc
  • The Fertility Class Announces Medical and Scientific Advisory Board
  • Major FDA Victory; Preservative-Free Ketamine Approved Ahead of November 10 Goal Date as Commercial Launch Opportunity Comes Into Focus for NRx Pharma
  • Steroids Outlet Expands Its Online Presence With New Bodybuilding and Fitness Publications
  • New Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX)
  • 2026 Thanksgiving Denture Special
Copyright © 2026 nyenta.com | Terms of Service | Privacy Policy | Contribute | Contact Us